Solutions
Company
Resources
Publications
Careers
Contact us
Skip to content
New and Noteworthy
Explore our latest insights, research, and stories
Newcastle Hospitals agree new data partnerships to improve care and treatment
Press releases
Genitourinary cancer research is incredibly promising, and real-world evidence is a key part of it
Real-world evidence
Case study
Prostate cancer
Genitourinary cancer
Powering a new era of treatment with real-world insights on >26K people with ovarian cancer
Real-world evidence
Case study
Ovarian cancer
Flatiron Health announces research to be presented at ISPOR 2025
Real-world evidence
Publications
Press releases
News
Featured topics
Real-world evidence
Clinical research
Point of care
Flatiron stories
Clinical decision support
Video
Machine learning
Press releases
Post marketing requirements
HTA and market access
Health equity
Case study
EHR-to-EDC
All the latest
Topics
Artificial intelligence
Clinical decision support
Clinical research
Inclusion
Data management
Drug Discovery
EHR-to-EDC
Flatiron stories
HTA and market access
Health equity
Label expansion
Machine learning
Methodology
Patient identification
Point of Care
Post marketing requirements
Practice management
Precision medicine
Prospective study
Protocol optimization
Real-World Evidence
Regulatory
Site identification
Technology & Engineering
Treatment patterns
Trial design
Unmet need
Value-based care
Content type
Article
Press releases
Case study
Publications
Customer interviews
Event recap
Video
Podcast
Clear
Apply filter
Showing 9 of
0
results
Newcastle Hospitals agree new data partnerships to improve care and treatment
Press releases
Concordance of response-based clinical trial and machine learning–generated real-world end points
ASCO Annual Meeting
Publication summary
Publications
Machine learning
Non-small cell lung cancer
Accrual of racially and ethnically underrepresented populations with multiple myeloma associated with centralized patient screening in a multicenter study
ASCO Annual Meeting
Clinical research
Publication summary
Publications
Molecular residual disease (MRD) in solid tumors
ASCO Annual Meeting
Clinical research
Publication summary
Publications
Real-world surgical and treatment patterns after neoadjuvant checkpoint inhibition in US patients with stage II/III non-small cell lung cancer
ASCO Annual Meeting
Publication summary
Publications
Treatment patterns
Non-small cell lung cancer
Real-world patient characteristics, treatment patterns, and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC): insights by PTEN status
ASCO Annual Meeting
Publication summary
Publications
Treatment patterns
Prostate cancer
Racial and ethnic differences in biomarker testing for targetable alterations among patients with HR+ HER2- metastatic breast cancer (mBC)
ASCO Annual Meeting
Health equity
Metastatic breast cancer
Impact of social determinants of health on mortality in diffuse large B-cell lymphoma (DLBCL) using real-world data
ASCO Annual Conference
Publication summary
Publications
Health equity
Diffuse large B-Cell lymphoma
A retrospective real-world study of first-line PD-(L)1 inhibitor use in patients with metastatic non-small cell lung cancer (mNSCLC)
ASCO Annual Conference
Publication summary
Publications
Non-small cell lung cancer
View more
